Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | CAD | P27708 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.32 |
| ▸ | MME | P08473 | 5/20 | 0.31 |
| ▸ | ACE | P12821 | 3/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.31 |
| ▸ | ITGAV | P06756 | 1/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.31 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL380941 | 1.00 | KMT2A (0.33) | KMT2AMCL1CADALDH1A1MAPT | |
| SCHEMBL9699920 | 1.00 | KMT2A (0.33) | KMT2AMCL1CADALDH1A1MAPT | |
| SCHEMBL9699954 | 1.00 | KMT2A (0.33) | KMT2AMCL1CADALDH1A1MAPT | |
| SCHEMBL9699985 | 0.98 | MCL1 (0.34) | KMT2AMCL1CADALDH1A1MAPT | |
| SCHEMBL737201 | 0.85 | ITGB3 (0.34) | CADCRBNGRIA2ITGB3ITGB2 | |
| SCHEMBL9172323 | 0.82 | CRBN (0.33) | KMT2AMCL1ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL4224698 | 0.74 | ITGB3 (0.35) | CADGRIA2ITGB3ITGB2ITGB1 | |
| SCHEMBL8563469 | 0.74 | ITGB3 (0.35) | CADGRIA2ITGB3ITGB2ITGB1 | |
| SCHEMBL1891354 | 0.73 | CAD (0.39) | KMT2AMCL1CADMMEACE | |
| SCHEMBL1891532 | 0.73 | CAD (0.39) | KMT2AMCL1CADMMEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12385916-B2 | Serum metabolic biomarkers and kit for detecting drug-resistant tuberculosis | Zhejiang SUKEAN Pharmaceutical Co., Ltd. (CN) | 2025-08-12 | — | — | US | claimed |
| US-12196753-B2 | Kit for detecting drug-resistant tuberculosis | Zhejiang SUKEAN Pharmaceutical Co., Ltd. (CN) | 2025-01-14 | — | — | US | claimed |
| US-20240295555-A1 | KIT FOR DETECTING DRUG-RESISTANT TUBERCULOSIS | Zhejiang SUKEAN Pharmaceutical Co., Ltd. (CN) | 2024-09-05 | — | — | US | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| US-20230349900-A1 | SERUM METABOLIC BIOMARKERS AND KIT FOR DETECTING DRUG-RESISTANT TUBERCULOSIS | Zhejiang SUKEAN Pharmaceutical Co., Ltd. (CN) | 2023-11-02 | — | — | US | claimed |
| US-20210088539-A1 | AUTOMATED SAMPLE QUALITY ASSESSMENT | METABOLON, INC. | 2021-03-25 | — | — | US | claimed |
| US-10890592-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2021-01-12 | — | — | US | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |
| US-12591974-B2 | Methods, devices, and systems for detecting analyte levels | OOVA, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-12385916-B2 | Serum metabolic biomarkers and kit for detecting drug-resistant tuberculosis | Zhejiang SUKEAN Pharmaceutical Co., Ltd. (CN) | 2025-08-12 | — | — | US | disclosed |
| US-12385916-B2 | Serum metabolic biomarkers and kit for detecting drug-resistant tuberculosis | Zhejiang SUKEAN Pharmaceutical Co., Ltd. (CN) | 2025-08-12 | — | — | US | disclosed |
| US-12329726-B2 | Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-06-17 | — | — | US | disclosed |
| US-12259397-B2 | Biomarkers related to organ function | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2025-03-25 | — | — | US | disclosed |
| EP-0979306-A4 | AN ASSAY FOR THE MEASUREMENT OF DNA SYNTHESIS RATES | UNIV GEORGE WASHINGTON (US) | 2004-09-01 | — | — | EP | disclosed |
| US-6355416-B1 | A NONRADIOACTIVE TRACER METHOD TO DETERMINE DNA SYNTHESIS BY ADMINISTERING STABLE ISOTOPE LABELLED PRECURSORS TO A SAMPLE THAT CONTAINS REPLICATING DNA WHICH IS INCORPORATED BY METABOLIC SALVAGE PATHWAY; DETECT THE ISOTOPE BY SPECTROMETER | THE GEORGE WASHINGTON UNIVERSITY | 2002-03-12 | — | — | US | disclosed |
| EP-0979306-A1 | AN ASSAY FOR THE MEASUREMENT OF DNA SYNTHESIS RATES | GEORGE WASHINGTON UNIVERSITY (US) | 2000-02-16 | — | — | EP | disclosed |
| WO-1998036095-A1 | AN ASSAY FOR THE MEASUREMENT OF DNA SYNTHESIS RATES | GEORGE WASHINGTON UNIVERSITY (US) | 1998-08-20 | — | — | WO | disclosed |
| US-5686491-A | CARNITINE | SIGMA-TAU PHARMACEUTICALS, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0569393-B1 | DERIVATIVES OF DICARBOXYLIC ACIDS HAVING SIX TO TWELVE CARBON ATOMS AND USE OF THESE DERIVATIVES AND DICARBOXYLIC ACIDS ALONE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR ENTERAL AND PARENTERAL NUTRITION | PINAROO LTD (IE) | 1995-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12591974-B2 | Methods, devices, and systems for detecting analyte levels | SHBG, GNRHR, LHCGR | KMT2A 3206/4885MCL1 2508/4885CAD 1516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.